Michael Allen Jerman insider trades

Open-market stock purchases and sales by Michael Allen Jerman, Director at Inhibitor Therapeutics, Inc, from SEC Form 4 filings since Mar 25, 2024.

Recent trades

DateStockTradeValue
May 4, 2026INTI Inhibitor Therapeutics, IncBought (not open market)—
Apr 29, 2026TCRT Alaunos Therapeutics, IncBought (not open market)$15.6K
Jan 12, 2026TCRT Alaunos Therapeutics, IncBought (not open market)$15.6K
Nov 21, 2025TCRT Alaunos Therapeutics, IncBought (not open market)$13.2K

Companies traded

  • INTI Inhibitor Therapeutics, Inc: other filings, last May 4, 2026
  • TCRT Alaunos Therapeutics, Inc: other filings, last Apr 29, 2026
  • TELO Telomir Pharmaceuticals, Inc: other filings, last Aug 27, 2024
  • MIRA Mira Pharmaceuticals, Inc: other filings, last Mar 25, 2024

Get free alerts when Michael Allen Jerman files a new trade →